The renoprotect effect of Shenhua recipe on 5/6 renal ablation rats

Zhongguo Zhongyao Zazhi

Volumn 30, Issue 5, 2005, Pages 377-381

  Li, Jian Jun ^a   Chen, Xiang Mei ^a   Gu, Yue ^a   Wei, Ri Bao ^a   Shi, Suo Zhu ^a   Yin, Zhong ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

5 6 renal ablation; Rat; Shenhua recipe

Indexed keywords

ALBUMINOID; CHOLESTEROL; CREATININE; HERBACEOUS AGENT;

ANIMAL; ARTICLE; ASTRAGALUS MEMBRANACEUS; ATRACTYLODES; BLOOD; BLOOD PRESSURE; CHEMISTRY; CHRONIC KIDNEY FAILURE; CURCUMA LONGA; DISEASE COURSE; DRUG COMBINATION; DRUG EFFECT; FEMALE; GLOMERULUS; ISOLATION AND PURIFICATION; MALE; MEDICINAL PLANT; METABOLISM; METHODOLOGY; NEPHRECTOMY; PATHOLOGY; RAT; WISTAR RAT;

ALBUMINS; ANIMALS; ASTRAGALUS MEMBRANACEUS; ATRACTYLODES; BLOOD PRESSURE; CHOLESTEROL; CREATININE; CURCUMA; DISEASE PROGRESSION; DRUG COMBINATIONS; DRUGS, CHINESE HERBAL; FEMALE; KIDNEY FAILURE, CHRONIC; KIDNEY GLOMERULUS; MALE; NEPHRECTOMY; PLANTS, MEDICINAL; RATS; RATS, WISTAR;

EID: 32644434341     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Noronha I L, Fujihara C K, Zatz R. The inflammatory component in progressive renal diseaseare interventions possible? Nephrol Dial Transplant, 2002, 17(3):363.
2. Lapinski R, Perico N, Remuzzi A, et al. Angiotensin II modulates glomerular capillary permselectivity in rat isolated perfused kidney. J Am Soc Nephrol, 1996, 7:653.
3. Taal M W, Zandi-Nejad K, Weening B, et al. Proinflammatory gene expression and macrophage recruitment in the rat remnant kidney. Kidney Int, 2000, 58(4):1664.
4. Badid C, Vincent M, McGregor B, et al. Mycophenolate mofetil reduces myofibroblast infiltration and collagen E deposition in rat remnant kidney. Kidney Int, 2000,58: 51.
5. Tapia E, Franco M, Sanchez-Lozada LG, et al. Mycophenolate mofetil prevents arteriolopathy and renal injury in subtotal ablation despite persistent hypertension. Kidney Int, 2003, 63(3):994.
6. Gadola L, Noboa O, Marquez M N, et al. Calcium citrate ameliorates the progression of chronic renal injury. Kdney Int, 2004, 65 (4):1224.
7. Fried L F, Orchard T J, Kasiske B L. Effects of lipid reduction on the progression of renal disease: a meta-analysis. Kidney Int, 2001, 59:260.
8. Ordonez J D, Hiatt R A, Killebrew E J, et al. The increased risk of coronary heart disease associated with nephrotic syndrome. Kidney Int, 1993, 44: 638.
9. Vogt L, Laverman G D, Dullaart R P F, et al. Lipid management in the proteinuric patient: do not overlook the importance of proteinuria reduction. Nephro Dial Transplant, 2004, 19(1): 5.
10. Wilmer W A, Rovin B H, Hebert CJ, et al. Management of Glomerular Proteinuria: A Commentary. J Am Soc Nephrol, 2003, 14(12): 3217.
11. Ruggenenti P, Mise N, Pisoni R, et al. Diverse effects of increasing lisinopril doses on lipid abnormalities in chronic nephropathies. Circulation, 2003, 107(4):586.